Vaccines
21 February 2014
Bavarian Nordic’s MVA-BN® Vaccine Platform Selected by U.S. Department of Defense for New Vaccine Development20 February 2014
FDA Accepts for Review Merck’s Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine12 February 2014
Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial5 February 2014
Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial of New Malaria Vaccine Approach3 February 2014
MOLOGEN AG: Final results from renal cancer trial with MGN1601 presented at ASCO Genitourinary Cancers Symposium31 January 2014
Icon Genetics successfully completes Phase I clinical study with personalized vaccines for treatment of non-Hodgkin’s lymphoma29 January 2014
Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus29 January 2014
Singapore’s First Influenza Vaccines Demonstrates Favorable Immunogenicity and Tolerability in Clinical Testing23 January 2014
GeoVax Announces Publication of Phase 2a Clinical Trial in The Journal of Infectious Diseases20 January 2014
Astellas and UMN Announce Summary Results in Phase III Clinical Trials of Seasonal Flu Vaccine ASP737414 January 2014
Agenus Announces Phase 2 Checkpoint inhibitor Combination Trial with Prophage Cancer Vaccine for Melanoma13 January 2014
GeoVax Announces Preliminary Top-Line Results for Phase 1 Therapeutic Vaccine Trial in HIV-Infected Patients13 January 2014
Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial9 January 2014
PaxVax Announces Positive Interim Results for Phase 3 Cholera Challenge Study; Clinical Trial Program to Proceed as Planned9 January 2014
Transgene Announces Topline Preliminary Results from Phase 2b Part of TIME Trial with TG4010 in Non-Small Cell Lung Cancer31 December 2013
Finnish HIV vaccine testing to beginNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports